Allianz Asset Management’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.52M Hold
164,078
0.01% 1174
2026
Q1
$7.52M Sell
164,078
-78,870
-32% -$4.56M 0.01% 991
2025
Q4
$18.1M Sell
242,948
-3,912
-2% -$282K 0.02% 642
2025
Q3
$18M Buy
246,860
+138,547
+128% +$10.5M 0.02% 625
2025
Q2
$7.49M Buy
108,313
+6,157
+6% +$319K 0.01% 920
2025
Q1
$4.62M Sell
102,156
-7,588
-7% -$450K 0.01% 1157
2024
Q4
$6.68M Buy
109,744
+25,975
+31% +$1.44M 0.01% 912
2024
Q3
$3.42M Buy
83,769
+14,476
+21% +$480K ﹤0.01% 1213
2024
Q2
$2.09M Buy
69,293
+614
+0.9% +$19.7K ﹤0.01% 1296
2024
Q1
$2.56M Buy
+68,679
New +$2.74M ﹤0.01% 1102
2023
Q1
Sell
-33,932
Closed -$328K 2141
2022
Q4
$328K Buy
33,932
+21,149
+165% +$319K ﹤0.01% 1801
2022
Q3
$240K Buy
+12,783
New +$334K ﹤0.01% 1620
2022
Q1
Sell
-127,354
Closed -$12.8M 2390
2021
Q4
$12.8M Sell
127,354
-8,801
-6% -$1.16M 0.01% 901
2021
Q3
$16.2M Buy
+136,155
New +$10.9M 0.01% 815

Other funds holding AFRM

Allianz Asset Management's AFRM Position: Q2 2026 in Review

Allianz Asset Management held its Affirm (AFRM) position steady in Q2 2026 at 164,078 shares worth $7.52M. The position accounts for 0.01% of the portfolio, ranked #1174.

Allianz Asset Management first reported a position in AFRM in Q3 2021 and has held it in 14 quarters since. The position peaked at $18.1M in Q4 2025. 659 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Allianz Asset Management held 164,078 shares of Affirm worth $7.52M as of Q2 2026.
  • Allianz Asset Management left its Affirm share count unchanged in Q2 2026.
  • Affirm made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1174 holding.
  • Allianz Asset Management first reported a position in Affirm in Q3 2021 and has held it in 14 quarters since.
  • Allianz Asset Management's Affirm position peaked at $18.1M in Q4 2025.
  • 659 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.